Twitter | Pretraživanje | |
Pretraživanje Osvježi
IRDiRC 15 h
Reply Retweet Označi sa "sviđa mi se"
Xtalks Webinars 7 h
How Do You Trust Your CRO to Manage Your Bioanalytical Drug Development? How to predict if a bioanalytical CRO has the capacity to support a company’s drug development needs? Learn how:
Reply Retweet Označi sa "sviđa mi se"
BPS Assessment 12 h
This upcoming workshop will help you better understand and its relevance in and
Reply Retweet Označi sa "sviđa mi se"
Anna Lubas 13 h
Outsourcing in the Cell & Gene Therapy Space - Steven Anderson PhD, CSO Covance, explains how specialized and coordinated capabilities aim to accelerate and reduce risk for sponsors.
Reply Retweet Označi sa "sviđa mi se"
Biotech 365 14 h
BerGenBio Meets Efficacy Endpoint For First Stage Of Phase II Trial With AXL Inhibitor Bemcentinib in Combination With Keytruda in NSCLC Patients Progressing on Immune Checkpoint Inhibitors
Reply Retweet Označi sa "sviđa mi se"
InnoSer 16 h
"We are happy to expand our services on neurodegenerative diseases to cover Parkinson’s disease", thanks to our new partnership with OrganoTherapeutics. Learn more at
Reply Retweet Označi sa "sviđa mi se"
Arcinova 19 h
Our CSO, Gareth Jenkins, is attending ’s in Glasgow. Be sure to say hello to him at the event and find out about our use of transformational technology for more efficient . Get in touch to arrange a meeting here:
Reply Retweet Označi sa "sviđa mi se"
Aptar 21 h
New development project? Find out how services can help you on your journey. Drop by Booth A68-A70 at
Reply Retweet Označi sa "sviđa mi se"
Boston Analytical 4. velj
Tomorrow we will be set up at the 4th Drug Development Summit in London! If you at the summit, don’t miss your chance to listen to our Director of Microbiology Jeff Heiser at 10 am!
Reply Retweet Označi sa "sviđa mi se"
IRDiRC 4. velj
Reply Retweet Označi sa "sviđa mi se"
Cellomatics Biosci 4. velj
This World Cancer Day, we recognise that our commitment to act will lead to powerful progress in reducing the global impact of cancer. Together we can win the battle against
Reply Retweet Označi sa "sviđa mi se"
Dehns 4. velj
is beginning to transform the historically tortuous and expensive process of bringing a new drug to the clinic.
Reply Retweet Označi sa "sviđa mi se"
Epistem 4. velj
We're excited to join for the Biomarker Series Conference on our home turf of Manchester! Swing by Booth 1 to discuss how we can accelerate your , or ask us where our favourite bars are 🍸
Reply Retweet Označi sa "sviđa mi se"
Debiopharm 4. velj
With our in , we won't give up the fight for better patient outcomes and the future of a cancer-free world
Reply Retweet Označi sa "sviđa mi se"
Lampgen Clinical Research 3. velj
Bristol-Myers withdraws Opdivo/Yervoy lung cancer EU application — but others are incoming – Endpoints News
Reply Retweet Označi sa "sviđa mi se"
CILcare | MAKING HEARING A PRIORITY 3. velj
Meet , CEO of CILcare, at the LSX World Congress in London on February 4-5! She will give a presentation about CILcare tomorrow at 4:30 PM during the Biotech Inv€€$table Showcase.
Reply Retweet Označi sa "sviđa mi se"
Roula Siddik 3. velj
Global Cancer Drug Market is expected to reach $176.509 million by 2025
Reply Retweet Označi sa "sviđa mi se"
Tatiana Prowell, MD 31. sij
Speaking solely as mom of a kid w/ , I’m grateful for the & thank all who joined & ran these . That said, a product that still requires allergen avoidance, 100% avail of epi, & can itself cause anaphylaxis is a 👎🏼 for me as a mom. 😞
Reply Retweet Označi sa "sviđa mi se"
MMS 31. sij
From a fifth floor highrise in , MMS redefines the CRO experience via its strong, insightful team of global colleagues in HITEC CIty. Start a conversation:
Reply Retweet Označi sa "sviđa mi se"
Exploristics 31. sij
Getting the most out of your clinical data? It’s never too late to get a biostatistics health check. Head to the new website to see how we support clinical development.
Reply Retweet Označi sa "sviđa mi se"